DIREVO announces validation of bestMab (08 May 2008) New approach for the optimization of therapeutic antibodies generates optiMIRA, an enhanced version of Adalimumab (Humira) (TM) shows 300-times tighter antigen binding than Humira®, and more than 15-fold...